Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Loh

Showing results (391-400 of 479) with videos related to

Pageof 48
Sort By:
Blood|January 7, 2018
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemiaKaren L Bride, Tiffaney L Vincent, Soo-Yeon Im, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2018
Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate RandomizationStuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, et al.
Blood|February 28, 2012
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group studyI-Ming Chen, Richard C Harvey, Charles G Mullighan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2020
Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic LeukemiaKimberly P Dunsmore, Stuart S Winter, Meenakshi Devidas, et al.
Nature|March 10, 2016
Corrigendum: Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemiaZhengshan Chen, Seyedmehdi Shojaee, Maike Buchner, et al.
Pediatric Blood & Cancer|March 9, 2019
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapyKatherine M Robinson, Wenjian Yang, Seth E Karol, et al.
Leukemia|January 19, 2017
Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemiaS E Karol, E Larsen, C Cheng, et al.
Haematologica|January 2, 2015
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemiaCharlotte M Niemeyer, Mignon L Loh, Annamaria Cseh, et al.
Leukemia|May 13, 2025
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemiaRuth W Wang'ondu, Emily Ashcraft, Ti-Cheng Chang, et al.
Leukemia|November 15, 2022
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategyLaurence C Cheung, Carlos Aya-Bonilla, Mark N Cruickshank, et al.
Pageof 48

Showing results (391-400 of 479) with videos related to

Sort By:
Pageof 48
Blood|January 7, 2018
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemiaKaren L Bride, Tiffaney L Vincent, Soo-Yeon Im, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2018
Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate RandomizationStuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, et al.
Blood|February 28, 2012
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group studyI-Ming Chen, Richard C Harvey, Charles G Mullighan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2020
Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic LeukemiaKimberly P Dunsmore, Stuart S Winter, Meenakshi Devidas, et al.
Nature|March 10, 2016
Corrigendum: Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemiaZhengshan Chen, Seyedmehdi Shojaee, Maike Buchner, et al.
Pediatric Blood & Cancer|March 9, 2019
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapyKatherine M Robinson, Wenjian Yang, Seth E Karol, et al.
Leukemia|January 19, 2017
Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemiaS E Karol, E Larsen, C Cheng, et al.
Haematologica|January 2, 2015
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemiaCharlotte M Niemeyer, Mignon L Loh, Annamaria Cseh, et al.
Leukemia|May 13, 2025
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemiaRuth W Wang'ondu, Emily Ashcraft, Ti-Cheng Chang, et al.
Leukemia|November 15, 2022
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategyLaurence C Cheung, Carlos Aya-Bonilla, Mark N Cruickshank, et al.
Pageof 48